Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 25.50
+0.54 (2.16%)
Jan 21, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 10.81 billion as of January 21, 2026. Its market cap has decreased by -20.41% in one year.
Market Cap
10.81B
Enterprise Value
8.71B
Revenue
2.74B
Ranking
n/a
PE Ratio
13.82
Stock Price
25.50
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has increased from 9.34B to 10.81B, an increase of 15.68%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 10.81B | 6.30% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 14.02B |
| Everest Medicines | 13.55B |
| Ascletis Pharma | 12.73B |
| Mirxes Holding Company | 11.61B |
| HBM Holdings | 10.81B |
| Nanjing Leads Biolabs | 10.70B |
| Lepu Biopharma | 9.76B |
| Abbisko Cayman | 9.33B |